The US has suspended the supply of ARVs and other essential drugs to the Kenya Medical Supplies Authority (Kemsa) as the new directives on foreign aid funding by Washington start to bite.
In a memo, the Mission for Essential Drugs and Supplies (MEDS) informed Kemsa Chief Executive Officer Dr Waqo Ejersa of its decision to suspend the processing of essential drugs funded by the United States.
The firm stated that all the United States Agency for International Development (USAID) funded commodities have been suspended until further notice.
MEDS was contracted by the US in 2020 to supply HIV commodities in Kenya, including ARVs, malaria, and tuberculosis (TB) drugs, among other medical consignments, following the Covid-19 billionaire scandal, which led to a loss of trust in Kemsa by the donor.
